MeiraGTx Holdings Plc (MGTX)
13.82
-0.32
(-2.26%)
USD |
NASDAQ |
Aug 28, 16:00
13.82
0.00 (0.00%)
After-Hours: 20:00
MeiraGTx Holdings Total Liabilities (Quarterly) : 180.67M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 180.67M |
| March 31, 2026 | 302.78M |
| December 31, 2025 | 256.84M |
| September 30, 2025 | 230.03M |
| June 30, 2025 | 195.76M |
| March 31, 2025 | 190.92M |
| December 31, 2024 | 201.92M |
| September 30, 2024 | 203.75M |
| June 30, 2024 | 186.61M |
| March 31, 2024 | 187.50M |
| December 31, 2023 | 319.99M |
| September 30, 2023 | 175.31M |
| June 30, 2023 | 186.74M |
| March 31, 2023 | 197.92M |
| December 31, 2022 | |
| September 30, 2022 | 178.74M |
| June 30, 2022 | 110.49M |
| Date | Value |
|---|---|
| March 31, 2022 | 126.41M |
| December 31, 2021 | 134.76M |
| September 30, 2021 | 115.50M |
| June 30, 2021 | 121.05M |
| March 31, 2021 | 118.88M |
| December 31, 2020 | 125.14M |
| September 30, 2020 | 113.96M |
| June 30, 2020 | 117.85M |
| March 31, 2020 | 119.74M |
| December 31, 2019 | 133.09M |
| September 30, 2019 | 122.86M |
| June 30, 2019 | 123.51M |
| March 31, 2019 | 113.44M |
| December 31, 2018 | 15.84M |
| September 30, 2018 | 8.892M |
| June 30, 2018 | 9.205M |
| March 31, 2018 | 14.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Xencor, Inc. | 221.73M |
| UroGen Pharma Ltd. | 384.99M |
| IDEAYA Biosciences, Inc. | 110.79M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.45M |
| Shareholders Equity (Quarterly) | 215.57M |
| Debt to Equity Ratio | 0.521 |
| Current Ratio | 3.758 |
| Net Debt Paydown Yield | -0.49% |